This study aims to understand the industry perspective on drivers and challenges for a successful la...
Read moreMedicine prices in Greece are set by the IRP. IRP is the process of using the prices in other countr...
Read moreIs the evidence base for high-cost CAR T-cell therapies Kymriah and Yescarta sufficient to be grante...
Read moreZolgensma launched in May 2019 in the US for $2.1 million, whilst Zynteglo was launched in the EU in...
Read moreThis study aimed to compare the use of financial agreements for oncology and non-oncology appraisals...
Read moreThis study from 2017 - 2019 compares the outcomes for oncology and non-oncology appraisals conducted...
Read moreIn England, to gain a positive recommendation for use within the NHS from NICE, pharmaceutical produ...
Read moreBy joining together, countries can combine their resources to potentially increase the efficiency of...
Read moreWhat is the future of precision medicine in the EU? The field of precision medicine is a complex are...
Read moreNICE will continue to offer joint advice with the Medicines and Healthcare products Regulatory Agenc...
Read more